← SynDRA
TEZACAFTOR
SynDRA canonical compound SYN0038169 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx |
| Primary target(s) | CFTR |
| Mechanism of action | CFTR channel agonist |
| Indication | cystic fibrosis |
| Disease area | pulmonary |
All known targets
Mechanisms of action (all sources)
- CFTR POSITIVE MODULATOR
- Cystic fibrosis transmembrane conductance regulator positive modulator
- CFTR channel agonist
- CFTR BINDER
- CFTR PHARMACOLOGICAL CHAPERONE
ATC classes
- OTHER RESPIRATORY SYSTEM PRODUCTS
Cross-references
Synonyms
- VX-661
- Tezacaftor component of symkevi
- Tezacaftor component of trikafta
- VX 661
- Tezacaftor (VX-661)
- Tezacaftor [USAN]
- (R)-1 (2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide
- VX661
- 8RW88Y506K
- 1-(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)-N-{1-[(2R)-2,3-DIHYDROXYPROPYL]-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2-YL)INDOL-5-YL}CYCLOPROPANE-1-CARBOXAMIDE
- UNII-8RW88Y506K
- 1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-[1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)indol-5-yl]cyclopropane-1-carboxamide
- CV6
- Cyclopropanecarboxamide, 1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-(1-((2R)-2,3-dihydroxypropyl)-6-fluoro-2-(2-hydroxy-1,1-dimethylethyl)-1H-indol-5-yl)-
- TEZACAFTOR [MI]
- TEZACAFTOR [INN]
- Tezacaftor (USAN/INN)
- TEZACAFTOR [WHO-DD]
- SCHEMBL322362
- VX 661;VX661;Tezacaftor
- CHEMBL3544914
- SCHEMBL10034144
- TEZACAFTOR [ORANGE BOOK]
- GTPL10199
- DTXSID40673070
- BDBM281054
- SYMKEVI COMPONENT TEZACAFTOR
- BCP07173
- cyclopropanecarboxamide, 1-(2,2-difluoro-1,3-benzodioxol-5-yl)-n-[1-[(2r)-2,3-dihydroxypropyl]-6-fluoro-2-(2-hydroxy-1,1-dimethylethyl)-1h-indol-5-yl]-
- EX-A1759
- TRIKAFTA COMPONENT TEZACAFTOR
- MFCD23106064
- s7059
- US10022352, Compound 315
- ZINC68206930
- CCG-269854
- CS-1078
- DB11712
Look up TEZACAFTOR in the interactive SynDRA portal →